Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
41.86
-0.32 (-0.76%)
At close: Feb 6, 2026
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 52.93 billion as of February 6, 2026. Its market cap has decreased by -38.37% in one year.
Market Cap
52.93B
Enterprise Value
48.36B
Revenue
1.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
41.86
Market Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 52.93B, an increase of 868.77%. That is a compound annual growth rate of 48.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 52.93B | -6.85% |
| Dec 31, 2025 | 56.82B | -36.26% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 52.39B |
| Pharmaron Beijing | 51.14B |
| Shanghai Allist Pharmaceuticals | 43.65B |
| Hebei Changshan Biochemical Pharmaceutical | 42.87B |
| Chongqing Zhifei Biological Products | 41.82B |
| Shanghai RAAS Blood Products | 41.68B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 37.34B |
| Asymchem Laboratories (Tianjin) | 35.94B |